A late-stage trial showed that oral semaglutide significantly reduced blood sugar in 10- to 17-year-olds. https://t.co/A6enJe8PkJ— The Wall Street Journal (@WSJ) April 23, 2026
A late-stage trial showed that oral semaglutide significantly reduced blood sugar in 10- to 17-year-olds.
@WSJ·X: @WSJ··1 min readSubscription
X
Continue reading on X: @WSJ
This article was sourced from X: @WSJ's RSS feed. Visit the original for the complete story.
Subscription required — this source requires an active subscription to read the full article.